Evidence map›Paper›PMID 23090956›Full record

ArticleInfection and immunity2013

A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.

M Piccioni, C Monari, S Kenno, E Pericolini, E Gabrielli, D Pietrella, S Perito, F Bistoni, T R Kozel, A Vecchiarelli

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. The capsule ofVirulence · 2019
    Review
  6. Article
  7. Review
  8. Variability in innate host immune responses to cryptococcosis.Memorias do Instituto Oswaldo Cruz · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. The Cell Biology of theFrontiers in cellular and infection microbiology · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

M PiccioniMicrobiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy.
C Monari
S Kenno
E Pericolini
E Gabrielli
D Pietrella
S Perito
F Bistoni
T R Kozel
A Vecchiarelli
University of Perugia · ITUniversity of Nevada, Reno · US

Funding

Cryptococcal polysaccharide-phagocytosis inhibitionR01AI014209 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 1985 to 2009
$1.9M
NIAID NIH HHS R01 AI014209
6 · The paper itself

Abstract

Capsular material of the opportunistic fungus Cryptococcus neoformans is composed mainly of a polysaccharide named glucuronoxylomannan (GXM). In this study, the effects of GXM were analyzed in an in vivo experimental system of lipopolysaccharide (LPS)-induced shock. Endotoxic shock was induced in mice by a single intraperitoneal injection of LPS from Escherichia coli. GXM treatment reduced the mortality of mice at early stages. Mice treated with LPS alone showed markedly increased plasma levels of tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), and IL-6, whereas mice that were also treated with GXM showed significantly lower plasma levels of these cytokines. This effect was related to a marked suppression of Akt and IκBα activation. Importantly, the inhibitory effect of GXM on proinflammatory cytokine secretion was reproduced by treatment with wortmannin, an inhibitor of the Akt transcription pathway. Our results indicate that GXM has a beneficial effect on endotoxic shock, resulting in a significant increase in the rate of survival by dampening the hyperinflammatory response.

Indexed as

AnimalsCryptococcus neoformansI-kappa B KinaseInflammationInterleukin-1betaInterleukin-6Lymph NodesMaleMiceMice, Inbred C57BLMyeloid Differentiation Factor 88PolysaccharidesProto-Oncogene Proteins c-aktSerumShock, SepticSignal TransductionglucuronoxylomannanI-kappa B KinaseInterleukin-1betaInterleukin-6Myd88 protein, mouseMyeloid Differentiation Factor 88PolysaccharidesProto-Oncogene Proteins c-aktTumor Necrosis Factor-alpha

Identifiers

PMID23090956
PMCPMC3536145
OpenAlexW2141413370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.